Filing Details
- Accession Number:
- 0001214659-21-002724
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-04 16:46:37
- Reporting Period:
- 2021-03-02
- Accepted Time:
- 2021-03-04 16:46:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1755970 | John Patrick Finn | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-02 | 358 | $8.82 | 43,358 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 1,517 | $26.66 | 44,875 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 827 | $23.33 | 45,702 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-02 | 2,702 | $145.35 | 43,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-02 | 358 | $0.00 | 358 | $8.82 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-02 | 1,517 | $0.00 | 1,517 | $26.66 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-02 | 827 | $0.00 | 827 | $23.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,773 | 2027-09-28 | No | 4 | M | Direct | |
48,544 | 2028-11-18 | No | 4 | M | Direct | |
26,475 | 2029-10-23 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
- The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.